Progression of Metastatic Pancreatic Cancer
6 Pogledi
• 07/30/23
0
0
Ugraditi
administrator
Pretplatnici
George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari